Hiroyasu Yokomise

Hiroyasu Yokomise

Auto-generated profile, based on publicly available information

Hiroyasu Yokomise

Department of General Thoracic, Breast and Endocrinological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2007 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
HYHiroyasu Yokomise
Hiroyasu Yokomise
MGMasashi Gotoh
Masashi Gotoh
TOTaku Okamoto
Taku Okamoto
YYYasumichi Yamamoto
Yasumichi Yamamoto
SIShinya Ishikawa
Shinya Ishikawa
CHCheng-Long Huang
Cheng-Long Huang

1 April 2016
Verified
Journal Article
Closed access
ATAkira Tadokoro
Akira Tadokoro
Nobuhiro KanajiNobuhiro Kanaji
Nobuhiro Kanaji
DLDage Liu
Dage Liu
HYHiroyasu Yokomise
Hiroyasu Yokomise
RHReiji Haba
Reiji Haba
SBShuji Bandoh
Shuji Bandoh

1 May 2007 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
HYHiroyasu Yokomise
Hiroyasu Yokomise
MGMasashi Gotoh
Masashi Gotoh
TOTaku Okamoto
Taku Okamoto
YYYasumichi Yamamoto
Yasumichi Yamamoto
SIShinya Ishikawa
Shinya Ishikawa
CHCheng-Long Huang
Cheng-Long Huang
The optimal surgical treatment for non-small cell lung cancer (NSCLC) with vertebral body invasion remains both controversial and challenging. We reviewed our experiences of NSCLC with vertebral body invasion, in which we have performed induction chemoradiotherapy followed by lung resection with en bloc partial vertebrectomy. Six NSCLC patients with vertebral invasion underwent an operation following chemoradiotherapy from January 2001 to July 2006. Vertebral invasion was evaluated by the chest CT and MRI findings. Either carboplatin-paclitaxel (n=3) or carboplatin-docetaxel (n=3) was used. Two cycles of chemotherapy were performed with concurrent radiation (50 Gy) treatment. In all of the six cases, a complete resection with en bloc partial vertebrectomy was performed with no operative mortality. The histological complete response rate and major response rate were 16.7% (1/6) and 83.3% (5/6), respectively. The 5-year overall survival rate was 67.7%. In addition, no local failure was observed after surgery. Surgery after chemoradiotherapy (carboplatin/paclitaxel or docetaxel and 50 Gy radiation) for NSCLC with vertebral invasion could thus be performed with acceptable morbidity.

5 February 2007 in Future Oncology
Verified
Journal Article
Closed access
CHCheng-Long Huang
Cheng-Long Huang
HYHiroyasu Yokomise
Hiroyasu Yokomise
AMAkira Miyatake
Akira Miyatake
Many molecules, including several regulators and various target genes, are involved in the biological functions of p53, thus making the p53 pathway rather complicated. However, recent clinical studies have demonstrated that most human cancers have an abnormality in some of the molecules associated with the p53 pathway. Most non-small cell lung cancers (NSCLCs) have either mutations of p53, a reduced p14 alternate reading frame expression, a reduced herpesvirus-associated ubiquitin-specific protease expression or a reduced p33 inhibitor of growth gene1b expression. As a result, the balance of expression of p53 target genes, such as p21, Bax and PUMA, regulates the biological behavior and determines the fate of tumor cells. To date, many studies on cancer gene therapy using these molecules associated with the p53 pathway have been performed to develop new strategies for treating NSCLC patients. Thus, the establishment of a comprehensive and simple evaluation protocol for the p53 pathway is required for clin...

1 December 2003 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
MGMasashi Gotoh
Masashi Gotoh
TOTaku Okamoto
Taku Okamoto
YYYasumichi Yamamoto
Yasumichi Yamamoto
DLDage Liu
Dage Liu
KKKotaro Kameyama
Kotaro Kameyama
HYHiroyasu Yokomise
Hiroyasu Yokomise

15 October 2003
Verified
Journal Article
Closed access
KKKotaro Kameyama
Kotaro Kameyama
CHCheng-Long Huang
Cheng-Long Huang
DLDage Liu
Dage Liu
DMDaiki Masuya
Daiki Masuya
TNTakashi Nakashima
Takashi Nakashima
HYHiroyasu Yokomise
Hiroyasu Yokomise